Intertek Share Discussion Threads

[arja] 05/10/2020 08:26

great start and not sure why it then fell sharply ! Must be some bad news out

[srichardson8] 31/7/2020 11:37

no complaints from me

[erogenous jones] 28/4/2020 10:49

Well, have just added a few today on current weakness

[erogenous jones] 31/10/2017 15:32

I have sold half my holding today to bank a healthy profit. My timing is not great, but paper profits are not a lot of good when building a portfolio!

[trytotakeiteasy] 05/10/2017 00:04

How did you select NMC? That has been a good one. I obviously need to get some stock tips from you!!!! Any ones you are looking at now...

[malcolmmm] 24/8/2017 09:58

Up 50% and rising, so made £10k , am into NMC another good one

[trytotakeiteasy] 01/8/2017 10:37

MALCOLMMM - How are you feeling now??

[trytotakeiteasy] 15/5/2017 23:21

Better than a slap in the face with a wet kipper!!!

[malcolmmm] 02/5/2017 10:55

Yes ,up 26.60% plus dividend, not bad

[trytotakeiteasy] 07/3/2017 10:44

MALCOLMMM - must be feeling pretty pleased now!!!

[malcolmmm] 06/1/2017 16:59

Am up 6.39% on these, not bad

[malcolmmm] 22/12/2016 09:58

Break out here

[malcolmmm] 09/12/2016 20:24

Starting to motor

[malcolmmm] 30/11/2016 09:16

Great chart and I am in profit, more to come hopefully. Recently recommended by Fat Prophets as a core holding

[arnu gutierrez] 25/11/2016 16:20

Potential reaction of Intertek Group (ITRK) to analysts' perspective on its stock http://crweworld.com/article/markets/46893/analysts-viewpoints-astrazeneca-azn-criteo-crto-whiting-petroleum-wll-fortis-fts-intertek-group-iktsy

[malcolmmm] 25/11/2016 09:26

agree am a buyer here great stock

[holdingtight] 05/11/2015 12:03

Anyone here. Just taken a punt, they seem over sold.

[corlis] 12/4/2015 18:15

Had a good ole study & i will be buying this tomorrow..

[jeffcranbounre] 28/1/2015 18:36

Interek is featured in today's ADVFN podcast. To listen click here> http://bit.ly/ADVFN0117 In today's podcast: - Simon Wajcenberg from K1T Capital markets says, according to his quant models, the markets are going to crash. Simon on Twitter is @k1tCapital - The micro and macro news - Plus the broker forecasts   Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below. Ten Bagger Tuesday (All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below: Suggest a stock (Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). You can subscribe to this podcast in iTunes by clicking HERE To follow me on Twitter click HERE As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions: Bronze - £50 (normally £73.82/year) Silver - £145 (normally £173.71/year) Level 2 - £350 (normally £472.94/year) Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information. Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing. Justin    

[miata] 16/5/2014 08:04

IMS and AGM. "We continue to anticipate improvement in growth and profitability in the second half of 2014 as market conditions are expected to improve and comparatives become easier." Cantor Group organic growth was just 0.3% in the four month to 30 April vs. +7% this time last year. Growth at constant exchange rates was +3.6% (+3.3% contribution from acquisitions) and at actual exchange rates sales were down 4.9%. There was strong growth in the consumer goods, commercial & electrical and chemicals & pharma divisions. However the group's overall performance was affected by deferrals of some energy industry capital projects and minerals also remained weak. In addition, the decision to exit low value contracts in the Industry division also had an adverse impact (this had already been flagged). Excluding these low value contracts, sales growth would have been +1.5%. The operating margin is said to have improved slightly reflecting the positive impact of restructuring. This is in-line, however, with our modelling assumptions, +20bps increase to 15.9% in FY14E. We are currently forecasting organic growth of 5% for FY14E, expecting this to be 2H weighted as comps start to ease (1H13A +6.3%; 2H13A +2.3%). However, the start of the year has been slightly slower than we had been anticipating with quarterly trends continuing to weaken (1Q13 +7%, 2Q13 +5.6%, 3Q13 +3%, 4Q13 +1.6%). The outlook statement highlights that management continues to anticipate improvement in growth and profitability in 2H14 as market conditions improve and comps ease. The shares are trading on a FY14E P/E of 20.9x and FY15E PE of 18.9x vs. a through the cycle average of 19x. However, we note that the discount with its two European listed peers is close to a 5 year high. Peers SGS SA (SGSN VX – NC) is on 24.7x FY14E and 22.2x FY15E and Bureau Veritas SA (BVI FP – NC) is on 23.6x and 21.2x respectively. Bureau Veritas recently reported on its 1Q14 trading figures. Group organic growth picked up from +1.6% 4Q13 to +2.7% 1Q14A. We maintain our HOLD recommendation and TP of 3,065p. RBC Our view: Q1 growth was a little weaker than expected, which results in another downgrade to forecasts. Whilst we like the fundamentals of the story and believe growth will improve into H2, valuation remains an issue and we are less optimistic than the market on medium-term margin progression. Key points: Q1 trading – The Q1 trading statement was a touch weak with organic revenue growth of only 0.3% (vs. 1.5% expected) for the first 4 months, with margins improved slightly. Growth has slowed further from the 1% in Nov/Dec, impacted by contract shedding as expected, along with weakerthan- expected activity in the energy infrastructure market and tough trading in Minerals. The outlook is mixed, pointing to variable market conditions, although management anticipates improvement in growth and profitability in H2. Forecasts reduced – We have reduced our 2014 and 2015 EPS forecasts by 3%. We now forecast organic revenue growth of 2.7% for the FY and +20bp on the margin. This clearly implies a material pick-up in H2, although comparatives do get easier (H113 +6.3%, H213 +2.3%). We expect the currency impact for the FY to be -7%, slightly more than the -6% we had previously forecast. Medium-term growth prospects sound – We continue to believe top-line prospects remain sound over the medium term, given that strong structural growth drivers remain (increasing need for energy infrastructure as middle class emerges, changing trade patterns, continuing technology and product development, increase in domestic consumers) and the potential for bolt-on acquisitions. The potential for the opening up of the Chinese market over time is a further opportunity. But we are below consensus – We are less optimistic on margins than the market – factoring in +30bp over 2 years vs. consensus of +70bp. This primarily reflects concerns around mix and investment costs. As a result, our 2015 forecasts were c6% below consensus (before today). Valuation – The stock has underperformed the market by 13% over the last 12 months, but consensus forecasts have come down by around 16% so the stock has kept its premium rating (15E PE 20x, FCF yield 3.9%). Whilst trading should be approaching a cyclical low point and growth should improve from here, valuation, in our view, remains full. Our price target nudges down to 2950p from 3000p as a result of the EPS downgrades today.